UPEXI, INC. Files Definitive Proxy Statement

TL;DR

UPEXI filed its proxy statement, shareholders vote soon.

AI Summary

UPEXI, INC. filed its definitive proxy statement (DEF 14A) on January 21, 2025, for its fiscal year ending June 30. The company, formerly known as GROVE, INC. until April 29, 2019, is based in Tampa, Florida, and operates in the medicinal chemicals & botanical products sector. The filing indicates no fee was required for this submission.

Why It Matters

This filing provides shareholders with essential information regarding company governance and upcoming voting matters, impacting their rights and the company's future direction.

Risk Assessment

Risk Level: low — This is a routine regulatory filing (DEF 14A) and does not contain new financial performance data or significant corporate actions.

Key Numbers

• 0630 — Fiscal Year End (Indicates the end of the company's financial reporting period.)

Key Players & Entities

• UPEXI, INC. (company) — Registrant
• GROVE, INC. (company) — Former company name
• 20190429 (date) — Date of name change
• 20250121 (date) — Filing date
• 3030 ROCKY POINT DRIVE SUITE 420 TAMPA FL 33607 (address) — Company business and mailing address

FAQ

Filing Documents

• upxi_def14a.htm (DEF 14A) — 76KB
• upxi_pre14aimg6.jpg (GRAPHIC) — 88KB
• upxi_pre14aimg7.jpg (GRAPHIC) — 59KB
• upxi_pre14aimg8.jpg (GRAPHIC) — 92KB
• 0001477932-25-000351.txt ( ) — 406KB

SECURITY OWNERSHIP OF CERTAIN BENEFICIAL OWNERS AND MANAGEMENT

SECURITY OWNERSHIP OF CERTAIN BENEFICIAL OWNERS AND MANAGEMENT 10 GENERAL 11 WHERE YOU CAN FIND MORE INFORMATION 11 2 Table of Contents Upexi, Inc. 3030 N. Rocky Point Drive, Suite 420, Tampa, FL 33607 NOTICE OF SPECIAL MEETING OF SHAREHOLDERS To Our Shareholders: We are pleased to announce that the Special Meeting of shareholders (the "Special Meeting") of Upexi, Inc. ("we," "our," "us," "Company," or "Upexi") will be held at 10:00 a.m. EDT on Monday, March 3, 2025. You are invited to participate in the Special Meeting. The purpose of the meeting is to consider and vote on the following matters: 1. Authorized Shares Amendment Proposal: To approve an amendment to our Certificate of Incorporation, as amended, to increase the number of authorized shares of our common stock, $.001 par value per share, from 5,000,000 to 100,000,000 and increase the number of authorized shares of our preferred stock, $.001 par value per share, from 500,000 to 10,000,000; and 2. Any other business that may properly be brought before the meeting or any adjournment of the meeting. The record date for the determination of shareholders entitled to vote at the Special Meeting is January 10, 2025 (the "Record Date"). You are entitled to participate in the Special Meeting if you were a holder of record of our Common Stock or Preferred Stock as of the close of business on the Record Date. Please note, if you plan to attend the Special Meeting in person, you will need to register in advance and receive an admission card to be admitted. Please follow the instructions on page 5 of the Proxy Statement. Please refer to the Q&A section below if you are a street name holder and would like to attend the Special Meeting. Record holders of shares may cast one vote for each share of our Common Stock and ten votes for each share of our Preferred Stock. Your vote is important. Whether or not you plan to attend the meeting, we ask that you appoint the Proxies named in the enclosed pr

SECURITY OWNERSHIP OF CERTAIN BENEFICIAL OWNERS AND MANAGEMENT

SECURITY OWNERSHIP OF CERTAIN BENEFICIAL OWNERS AND MANAGEMENT The following table sets forth the ownership, as of December 16, of our Common Stock by each of our directors, by all of our executive officers and directors as a group and by each person known to us who is the beneficial owner of more than 5% of any class of our securities. As of January 10, there were 1,240,924 shares of our Common Stock issued and outstanding. All persons named have sole or shared voting and investment control with respect to the shares, except as otherwise noted. The number of shares described below includes shares which the beneficial owner described has the right to acquire within 60 days of the date of the prospectus. Unless otherwise indicated, the address for each beneficial owner is c/o Upexi, Inc., 3030 North Rocky Point Drive Suite 420, Tampa, Florida 33607. Name and Address of Beneficial Owner Amount and Nature of Beneficial Ownership Percentage of Class (1) Allan Marshall 288,229 (2) 21.43 % Gene Salkind 130,287 (3) 10.45 % Andrew Norstrud 53,057 (4) 4.15 % Lawrence Dugan 7,778 (5) .62 %* Thomas Williams 6,389 (6) 0.51 %* Directors and Executive Officers as a Group 291,988 34.65 % __________ * Represents less than 1% of the number of shares of our Common Stock outstanding (1) Under Rule 13d-3, a beneficial owner of a security includes any person who, directly or indirectly, through any contract, arrangement, understanding, relationship, or otherwise has or shares: (i) voting power, which includes the power to vote, or to direct the voting of shares; and (ii) investment power, which includes the power to dispose or direct the disposition of shares. Certain shares may be deemed to be beneficially owned by more than one person (if, for example, persons share the power to vote or the power to dispose of the shares). In addition, shares are deemed to be beneficially owned by a person if the person has the right to acquire the shar

View Full Filing

View this DEF 14A filing on SEC EDGAR